-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ksrj2zkL6eC19OTzJN+UUHlo/tpkB9SRCNb8xKkMsrLlp2gtwkR0h22GE4NltdlT wUDMwgTruEROOLkj+LmNUA== 0001225208-09-002663.txt : 20090203 0001225208-09-002663.hdr.sgml : 20090203 20090203142710 ACCESSION NUMBER: 0001225208-09-002663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090130 FILED AS OF DATE: 20090203 DATE AS OF CHANGE: 20090203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GROBSTEIN MICHAEL CENTRAL INDEX KEY: 0001222342 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 09564409 BUSINESS ADDRESS: BUSINESS PHONE: 3179712022 MAIL ADDRESS: STREET 1: C/O GUIDANT CORP STREET 2: 111 MONUMENT CIRCLE #2900 CITY: INDIANAPOLIS STATE: IN ZIP: 46204-5129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 doc4.xml X0303 4 2009-01-30 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001222342 GROBSTEIN MICHAEL BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 Deferred Share Units 0 2009-01-30 4 A 0 1351.19 0 A Common Stock, $0.10 par value 1351.19 10857.35 D Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. Accrual of deferred share units resulting from the transfer of Mr. Grobstein's deferred compensation balance into a fund tracked against company stock price. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. /s/ Sonia Vora, Attorney-in-Fact 2009-02-03 -----END PRIVACY-ENHANCED MESSAGE-----